45
0
|
25

CONGRATULATIONS

YOUR INTERVENTION HAS RESULTED
IN A CHANGE IN RBC SICKLING OF:

-0%

For more information and to check the Abbreviated Prescribing Information, please scan the QR code.

Reference:
Glaros, A.K., Razvi, R., Shah, N. and Zaidi, A.U. (2021). Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor. Therapeutic Advances in Hematology, 12, p.20406207211001136.